EDAP TMS S.A.
NASDAQEDAP short interest doubled in one week to 39,714 shares as of April 29, marking an 98.9% surge. The medical device stock rose 0.9% on the day despite the heightened bearish positioning. Cost to borrow stands at 1.02%, up 5.2% weekly. Utilization remains low at 5.6%. Next earnings April 7, with analyst target at $5.50 versus current $3.31 price.
Snapshot as of 8 May 2026
EDAP TMS goes into its Q1 2026 earnings call on May 7 carrying a month of losses and a freshly cut analyst target — with options traders, unusually, leaning the other way. The most pressing backdrop is the price. EDAP…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for EDAP — free to start on ORTEX.
Sign up for free →Open EDAP on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live EDAP data →